OAM
AMRX icon

OP Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

OP Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,667
Closed -$220K – 770
2026
Q1 		$220K Sell
17,667
-75,988
-81% -$1.02M ﹤0.01% 730
2025
Q4 		$1.18M Sell
93,655
-29,612
-24% -$339K 0.01% 561
2025
Q3 		$1.23M Buy
123,267
+73,736
+149% +$662K 0.02% 554
2025
Q2 		$401K Hold
49,531
– – 0.01% 687
2025
Q1 		$415K Buy
+49,531
New +$413K 0.01% 691

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

OP Asset Management's AMRX Position: Q2 2026 in Review

OP Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 17,667 shares — an estimated $220K sold.

OP Asset Management first reported a position in AMRX in Q1 2025 and held it in 5 quarters. The position peaked at $1.23M in Q3 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • OP Asset Management reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 17,667 Amneal Pharmaceuticals shares in Q2 2026, an estimated $220K.
  • OP Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2025 and held it in 5 quarters.
  • OP Asset Management's Amneal Pharmaceuticals position peaked at $1.23M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.